Substance misuse and early psychosis

References

• Hambrecht M, Hafner H. Substance abuse and the onset of schizophrenia. Biological Psychiatry 1996; 40: 1155–1163
   PubMed Web of Science ®Google Scholar
• Cantwell R, Brewen J, Glazebrook C, et al. Prevalence of substance misuse in first episode psychosis. British Journal of Psychiatry 1999; 174: 150–153
   PubMed Web of Science ®Google Scholar
• Verdoux H, Liraud F, Gonzales B, Assens F, Abalan F, van Os J. Suicidality and substance misuse in first-admitted subjects with psychotic disorder. Acta Psychiatrica Scandinavica 1999; 100: 389–395
   PubMed Web of Science ®Google Scholar
• Van Mastrigt S, Addington J, Addington D. Substance misuse at presentation to an early psychosis program. Social Psychiatry and Psychiatric Epidemiology 2004; 39: 69–72
   PubMed Web of Science ®Google Scholar
• Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatrica Scandinavica 2007; 115: 304–309
   PubMed Web of Science ®Google Scholar
• Lambert M, Conus P, Lubman DI, et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatrica Scandinavica 2005; 112: 141–148
   PubMed Web of Science ®Google Scholar
• Sim K, Swapna V, Mythily S, et al. Psychiatric comorbidity in first-episode psychosis: the Early Psychosis Intervention Program (EPIP) experience. Acta Psychiatrica Scandinavica 2004; 109: 23–29
   PubMed Web of Science ®Google Scholar
• Korkeila JA, Svirskis T, Heinimaa M, et al. Substance abuse and related diagnoses in early psychosis. Comprehensive Psychiatry 2005; 46: 447–452
   PubMed Web of Science ®Google Scholar
• Sorbara F, Liraud F, Assens F, Abalan F, Verdoux H. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. European Psychiatry 2003; 18: 133–136
   PubMed Web of Science ®Google Scholar
• Wade D, Harrigan S, Edwards J, Burgess PM, Whelan G, McGorry PD. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. British Journal of Psychiatry 2006; 189: 229–234
   PubMed Web of Science ®Google Scholar
• Boydell J, Dean K, Dutta R, Giouroukou E, Fearon P, Murray R. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis. Schizophrenia Research 2007; 93: 203–210
   PubMed Web of Science ®Google Scholar
• Grech A, Van Os J, Jones PB, Lewis SW, Murray RM. Cannabis use and outcome of recent onset psychosis. European Psychiatry 2005; 20: 349–353
   PubMed Web of Science ®Google Scholar
• Veen N, Selten J-P, van der Tweel I, Feller WG, Hoek HW, Kahn RS. Cannabis use and age of onset of schizophrenia. American Journal of Psychiatry 2004; 161: 501–506
   PubMed Web of Science ®Google Scholar
• Barnes TRE, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM. Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry 2006; 188: 237–242
   PubMed Web of Science ®Google Scholar
• Pencer A, Addington J. Substance use and cognition in early psychosis. Journal of Psychiatry and Neuroscience 2003; 28: 48–54
   PubMed Web of Science ®Google Scholar
• Sevy S, Robinson DG, Solloway S, et al. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica 2001; 104: 367–374
   PubMed Web of Science ®Google Scholar
• Stirling J, Lewis S, Hopkins R, White C. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophrenia Research 2005; 75: 135–137
   PubMed Web of Science ®Google Scholar
• Hambrecht M, Hafner H. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Australian and New Zealand Journal of Psychiatry 2000; 34: 469–475
   Web of Science ®Google Scholar
• Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychological Medicine 2003; 33: 15–21
   PubMed Web of Science ®Google Scholar
• Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen JD. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study. Psychological Medicine 2003; 33: 23–32
   PubMed Web of Science ®Google Scholar
• Miller P, Lawrie SM, Hodges A, Clafferty R, Cosway R, Johnstone EC. Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Social Psychiatry and Psychiatric Epidemiology 2001; 36: 338–342
   PubMed Web of Science ®Google Scholar
• Phillips LJ, Curry C, Yung AR, Yuen HP, Adlard S, McGorry PD. Cannabis use is not associated with the development of psychosis in an ‘ultra’ high risk group. Australian and New Zealand Journal of Psychiatry 2002; 36: 800–806
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Witton J, Murray R. Causal association between cannabis and psychosis: examination of the evidence. British Journal of Psychiatry 2004; 184: 110–117
   PubMed Web of Science ®Google Scholar
• Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self-reported cannabis use as a risk factor for schizophrenia: further analysis of the 1969 Swedish conscript cohort. British Medical Journal 1002; 325: 1199–1201
   Google Scholar
• Van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. American Journal of Epidemiology 2002; 156: 319–327
   PubMed Web of Science ®Google Scholar
• Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal 2002; 325: 1212–1213
   PubMed Web of Science ®Google Scholar
• Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biological Psychiatry 2005; 57: 1117–1127
   PubMed Web of Science ®Google Scholar
• McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006; 101: 1473–1478
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Roxburgh A, Black E, et al. The epidemiology of methamphetamine use and harm in Australia. Drug and Alcohol Review 2008; 27: 243–252
   PubMed Web of Science ®Google Scholar
• Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review 2008; 27: 253–262
   PubMed Web of Science ®Google Scholar
• Chen C-K, Lin S-K, Sham PC, et al. Pre-morbid characteristics and comorbidity of methamphetamine users with and without psychosis. Psychological Medicine 2003; 33: 1407–1414
   PubMed Web of Science ®Google Scholar
• Chen CK, Lin SK, Sham PC, Ball D, Loh el-W, Murray RM. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. American Journal of Medical Genetics 2005; 136: 87–91
   PubMedGoogle Scholar
• Addington J, Addington D. Effect of substance misuse in early psychosis. British Journal of Psychiatry 1998; 172(Suppl. 33)134–136
   Google Scholar
• Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases. British Journal of Psychiatry 2005; 187: 510–515
   PubMed Web of Science ®Google Scholar
• Addington J, Addington D. Impact of an early psychosis program on substance use. Psychiatric Rehabilitation Journal 2001; 25: 60–67
   PubMed Web of Science ®Google Scholar
• Kavanagh DJ, Young R, White A, . Start Over and Survive: a brief intervention for substance misuse in early psychosis. Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery, HL Graham, A Copello, MJ Birchwood, KT Mueser, et al. Wiley, Chichester 2003; 245–258
   Google Scholar
• Kavanagh DJ, Young R, White A, et al. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review 2004; 23: 151–155
   PubMed Web of Science ®Google Scholar
• Kemp R, Harris A, Vurel E, Sitharthan T. Stop Using Stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry 2007; 15: 490–492
   PubMed Web of Science ®Google Scholar
• Farrelly S, Harris MG, Henry LP, et al. Prevalence and correlates of comorbidity 8 years after a first psychotic episode. Acta Psychiatrica Scandinavica 2007; 116: 62–70
   PubMed Web of Science ®Google Scholar
• Edwards J, Hinton M, Elkins K, Athanasopoulos O. Cannabis and first-episode psychosis: the CAP Project. Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery, HL Graham, A Copello, MJ Birchwood, KT Mueser. Wiley, Chichester 2003; 282–304
   Google Scholar